Skip to main content
. Author manuscript; available in PMC: 2007 Mar 15.
Published in final edited form as: J Appl Physiol (1985). 2005 Sep 15;100(1):336–342. doi: 10.1152/japplphysiol.00890.2005

Table 1.

Arterial blood sample analysis and MABP before and after transfusion of solutions of hemoglobin polymer or albumin

Hematocrit, %
Hemoglobin, g/dl
Paco2, Torr
MABP, mmHg
Pretransfusion Posttransfusion Pretransfusion Posttransfusion Pretransfusion Posttransfusion Pretransfusion Posttransfusion
Hemoglobin groups
Vehicle 36±3 27±4* 11.0±0.7 9.7±1.1* 37±3 37±4 95±7 94±10
WIT-002 38±1 29±1* 12.0±0.5 10.6±0.2* 38±2 38±2 100±4 98±4
DDMS 38±2 28±4* 11.9±0.6 9.7±1.7* 37±1 39±3 97±13 100±12
HET-0016 40±2 27±3* 12.5±0.6 10.4±0.9* 39±1 39±3 94±4 97±5
L-NNA 39±2 30±3* 12.1±0.7 10.7±0.8* 37±2 37±2 98±8 98±9
L-NNA + DDMS 38±2 27±2* 11.6±0.5 10.7±0.4 37±1 37±1 95±9 97±9
Albumin groups
Vehicle 39±1 25±1* 12.0±0.4 7.6±0.3* 38±2 40±3 98±5 93±6*
Glibenclamide 39±2 24±2* 12.1±1.4 7.9±0.7* 39±2 40±2 99±12 97±10

Values are means ± SD. Paco2, arterial Pco2; MABP, mean arterial blood pressure; WIT-002, 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid; DDMS, N-methylsulfonyl-12,12-dibromododec-11-enamide; HET-0016, N-hydroxy-N′-(4-butyl-2-methylphenyl)-formamidine; L-NNA, Nω-nitro-L-arginine.

*

P < 0.05 from pretransfusion by paired t-test.